Marc G Ghany, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
14
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
0
PubMed author-name match
Trials
Studies that name Marc G Ghany, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:54 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06092333 · VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis BNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · active not recruiting · Chronic Hepatitis B · principal investigator
- N/ANCT05669677 · Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver DiseaseNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Chronic or Recovered Hepatitis B, Chronic or Recovered Hepatitis C, Chronic or Recovered Hepatitis D · principal investigator
- Ph2NCT03575208 · Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · withdrawn · Chronic Hepatitis B · principal investigator
- Ph4NCT03520660 · People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral AgentsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · active not recruiting · Diabetes Mellitus, Hepatitis C, Chronic, Cardiovascular Diseases · principal investigator
- N/ANCT03248622 · Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C InfectionNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Hepatitis B · principal investigator
- Ph2NCT02468648 · Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Chronic Hepatitis C · principal investigator
- Ph2NCT02364336 · Add-on Peginterferon Following Nucleos(t)Ide Analogue TreatmentNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Chronic Hepatitis B · principal investigator
- N/ANCT02190253 · Seroprevalence of Hepatitis E in People With an Organ TransplantNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Hepatitis E · principal investigator
- Ph2NCT01888900 · New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis CNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Cirrhosis, Chronic Hepatitis C, Hepatitis C · principal investigator
- N/ANCT01581554 · Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis BNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative · principal investigator
- N/ANCT01182311 · Duration of Long-term Immunity After Hepatitis B Virus ImmunizationNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Hepatitis B · principal investigator
- N/ANCT00825877 · Long-term Follow-up of HALT-C Sustained Virological RespondersNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Hepatitis C, Hepatocellular Carcinoma, Ascites · principal investigator
- Ph2NCT00735969 · High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Chronic Hepatitis C · principal investigator
- Ph2NCT00524173 · Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis BNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · terminated · Hepatitis B · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.